1. Home
  2. BFS vs VIR Comparison

BFS vs VIR Comparison

Compare BFS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFS

Saul Centers Inc.

HOLD

Current Price

$31.55

Market Cap

759.2M

Sector

Real Estate

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.00

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFS
VIR
Founded
1993
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
759.2M
825.0M
IPO Year
1993
2019

Fundamental Metrics

Financial Performance
Metric
BFS
VIR
Price
$31.55
$6.00
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$25.73
AVG Volume (30 Days)
75.0K
2.0M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
7.48%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$282,618,000.00
$16,860,000.00
Revenue This Year
$8.14
N/A
Revenue Next Year
$5.75
$46.25
P/E Ratio
$27.66
N/A
Revenue Growth
5.61
N/A
52 Week Low
$29.16
$4.16
52 Week High
$39.15
$14.45

Technical Indicators

Market Signals
Indicator
BFS
VIR
Relative Strength Index (RSI) 54.81 48.14
Support Level $31.00 $5.73
Resistance Level $31.60 $6.16
Average True Range (ATR) 0.58 0.36
MACD -0.00 -0.08
Stochastic Oscillator 62.50 22.93

Price Performance

Historical Comparison
BFS
VIR

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: